期刊文献+

OX-LDL及辛伐他汀对平滑肌细胞PKC活性和胞内Ca^(2+)的影响 被引量:3

Effect of OX-LDL and simvastatin on PKC activity and cytosolic free Ca^(2+) in cultured rat aortic smooth muscle cells
下载PDF
导出
摘要 目的 :探讨OX -LDL是否对大鼠主动脉平滑肌细胞 (ASMC)蛋白激酶C(PKC)活性和胞浆内游离钙([Ca2 + ]i)水平有影响。方法 :应用γ - [3 2 P]-ATP磷酸转移法和Fluo - 3/Am荧光负载、流式细胞术分别检测PKC活性和胞内 [Ca2 + ]i)水平。结果 :OX -LDL呈剂量依赖方式促进ASMCPKC总活性增加 ,并可引起ASMC中PKC发生浆膜的转移。胞浆内 [Ca2 + ]i以 2个时相升高 ,即快速相和持续相。而辛伐他汀能明显抑制OX -LDL引起的ASMC中PKC活性的浆膜转移 ,并显著降低持续相胞浆内钙水平 ,而对快速相无影响。结论 :OX -LDL能引起ASMC内信号通路PKC及 [Ca2 + ]i的动态变化 ,二者密切相关。 AMI: To clarify whether OX-LDL and simvastatin can induce the changes of PKC activity and cytosolic free Ca 2+ in rat aortic smooth muscle cells (ASMC). METHODS: PKC activity and cytosolic free Ca 2+ were measured by its ability to transfer phosphate from ATP to lysine-rich histone and flow cytometric analysis after loading with the Ca 2+ dye fluo 3/Am, respectively. RESULTS: OX-LDL increased PKC total activity in a dose-dependent manner and induced translocation of PKC from the cytosolic to membrane, while OX-LDL induced biphasic [Ca 2+ ]i responses including the rapid initial transient phase and the sustained phase. When simvastatin was added, the translocation of PKC was markedly decreased and simvastatin did not impair the initial peak response to OX-LDL but significantly reduced the subsequent plateau phase. CONCLUSSION: OX-LDL can induce dynamic changes of signal transduction of PKC and cytosolic free Ca 2+ in ASMC and these two events are closely linked.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2002年第4期344-347,共4页 Chinese Journal of Pathophysiology
基金 国家重点基础研究 (973)项目 (G2 0 0 0 0 5 6 90 3)
关键词 脂蛋白类 LDL 辛伐他汀 蛋白激酶C 平滑肌细胞 动脉粥样硬化 Lipoproteins, LDL Simvastatin Muscle, smooth Cells Protein kinase C Calcium
  • 相关文献

参考文献2

共引文献10

同被引文献15

  • 1叶任高.内科学[M].第5版[M].北京:人民卫生出版社,2000.15-18.
  • 2Terje R, Pedersen TR, Lars Wilhelmson, et al. Scandinavian Simvastatin Survivlal Study Group. Radomized trial of chloester of lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survivlal Study (4s) [ J ]. Lancent, 1994,344 : 1383 - 1389.
  • 3The long- term intervention with pravastin ih ischaemic disase(LIPID) study Group. Prevention of cardiovascular events and death with pravastin in patients with coronary heart and a broud range of initial cholesterol levels [ J ]. Nengl J Med,1998,339 : 1349 - 1357.
  • 4Miki Nagase, Shinya Kaname, Takashi Nagase, et al. Expression of LOX-1, an Oxidized Low-Density Lipoprotein Receptor, in Experimental Hypertensive Glomerulosclerosis. J Am Soc Nephrol, 2000, 11 : 1826- 1836.
  • 5Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997, 386: 73-77.
  • 6Nagase M, Abe J, Takahashi K, et al. Genomie organization and regulation of expression of the lectinlike oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem, 1998, 273: 33702-33707.
  • 7Aoyama T, Fujiwara H, Masaki T, et al. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol, 1999, 31: 2101-2114.
  • 8Li DY, Yang BC, Mehta JL. Ox-LDL enhances anoxia-reoxygenation-mediated apoptosis in human coronary endothelial cells: Role of PKC, PTK, Bcl-2 and Fas. Am J Physiol, 1998, 275: H568-576.
  • 9Hanfang Zhang, Connie Snead, John D. Catravas. Nitric Oxide Differentially Regulates Induction of Type Ⅱ Nitric Oxide Synthase in Rat Vascular Smooth Muscle Cells Versus Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology,2001, 21 : 529-535.
  • 10JL Mehta. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atheroselerosis. Can J Cardiol. 2004, 20 (Suppl B) : 32B-36B.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部